Does TELMISARTAN Cause Hyperphosphataemia? 10 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Hyperphosphataemia have been filed in association with TELMISARTAN (telmisartan). This represents 0.2% of all adverse event reports for TELMISARTAN.
10
Reports of Hyperphosphataemia with TELMISARTAN
0.2%
of all TELMISARTAN reports
10
Deaths
10
Hospitalizations
How Dangerous Is Hyperphosphataemia From TELMISARTAN?
Of the 10 reports, 10 (100.0%) resulted in death, 10 (100.0%) required hospitalization, and 10 (100.0%) were considered life-threatening.
Is Hyperphosphataemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TELMISARTAN. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does TELMISARTAN Cause?
Drug ineffective (685)
Dizziness (569)
Dyspnoea (556)
Headache (508)
Fall (500)
Nausea (486)
Hypertension (477)
Blood pressure increased (473)
Diarrhoea (467)
Malaise (458)
What Other Drugs Cause Hyperphosphataemia?
ALLOPURINOL (139)
LANSOPRAZOLE (138)
ACETAMINOPHEN (132)
SEVELAMER (129)
ONDANSETRON (127)
CALCITRIOL (125)
IPRATROPIUM (123)
ALBUTEROL (122)
METRONIDAZOLE (120)
HYDROMORPHONE (118)
Which TELMISARTAN Alternatives Have Lower Hyperphosphataemia Risk?
TELMISARTAN vs TELOTRISTAT ETHYL
TELMISARTAN vs TEMAZEPAM
TELMISARTAN vs TEMODAR
TELMISARTAN vs TEMOZOLOMIDE
TELMISARTAN vs TEMSIROLIMUS